Each year, the annual Myeloma Canada Scientific Roundtable brings together over 80 stakeholders, including Canada's top myeloma experts from coast to coast, scientists from the USA and Europe, our industry research partners and patients. The meeting is an incubator for clinical trial ideas and supports our goal of developing high-impact made-in- Canada clinical trials for patients across the country. The MCRN's clinical trial portfolio continues to grow and with the recent launch of the MCRN Canadian Multiple Myeloma Database, we will now be able to gather patient outcome data from across the country to better identify the optimal treatment approaches.
2017 Scientific Roundtable
On September 15 and 16, Myeloma Canada hosted the 8th annual Myeloma Canada Scientific Roundtable in Montreal. Co-chaired by Dr. Jonathan Keats from Phoenix, Arizona and Dr. Victor Zepeda from Calgary, the meeting brought together over 90 stakeholders, including Canada's top myeloma experts from coast to coast, scientists from the USA and Europe, our industry research partners and patient contributors. This year's international guest speakers included Dr. Ashutosh Wechalekar from London, UK, Dr. Peter Voorhees from Chapel Hill, NC, Dr. Dirk Hose from Heidelberg, DE, Dr. Shaji Kumar from Rochester, MN, Dr. Jesús Berdeja from Nashville, TN, and Dr. Rafael Fonseca from Scottsdale, AZ.